Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach called targeted protein modulation to treat a broad range of diseases. Our focus is on developing targeted therapies to treat cancer including novel, small molecule immuno-oncology agents.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
July 23, 2020
July 13, 2020
June 25, 2020
More events are coming soon.